REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
353
Frequently Asked Questions
What is Market Cap of Regenxbio Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Regenxbio Inc market cap is $459.17M.
What is the 52-week high for Regenxbio Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Regenxbio Inc 52 week high is $13.48 as of September 16, 2025.
What is the 52-week low for Regenxbio Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Regenxbio Inc 52 week low is $5.04 as of September 16, 2025.
What is Regenxbio Inc stock price today?
Regenxbio Inc stock price today is $9.34.
What was Regenxbio Inc stock price yesterday?
Regenxbio Inc stock price yesterday was $9.09.
What is the PE ratio of Regenxbio Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Regenxbio Inc’s P/E ratio is -2.62.
What is the Price-to-Book ratio of Regenxbio Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Regenxbio Inc P/B ratio is 2.1436.
What is the 50-day moving average of Regenxbio Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Regenxbio Inc 50-day moving average is $8.76.